Antoniazzi C, Cnockaert X, Michel P
Geriatrics Department, Centre hospitalier René-Dubos - Pontoise site, 6 avenue de l'Ile de France, 95300, Pontoise, France.
Gerontology Unit, Centre Hospitalier de Beauvais, 40 avenue Léon Blum, 60021, Beauvais Cedex, France.
Sci Rep. 2025 May 15;15(1):16837. doi: 10.1038/s41598-025-99752-9.
In France, drug-related iatrogenesis is considered to be the cause of numerous emergency departments consultations and the onset of many disabling comorbidities in elderly people. Deprescribing potentially inappropriate drugs for the older adults could help prevent this. However studies have shown that patients are reluctant to take this approach. The aim of this study was to describe the barriers and attitudes of older adults patients cared for in the French geriatric network as regards deprescribing potentially inappropriate prescription. This study was a non-interventional, multicentric, prospective cross-sectional one carried out with patients aged 75 and over, hospitalized in the French geriatric network. Data was collected using the "revised Patients' attitude toward deprescribing" questionnaire, validated in French. Analysis of the results showed that patients had a high opinion of their treatments and did not see them as a bother. Nonetheless, although 60% were in favour of this approach overall, they seemed more reluctant to stop their antihypertensive, hypnotic and benzodiazepine treatments. This study led to better understanding of the attitudes of older adults French people towards deprescribing and opens up practical avenues for encouraging discussion on treatments and better acceptance of deprescribing. Clinical trials registration NCT05327634.
在法国,药物相关的医源性疾病被认为是导致众多急诊就诊以及许多老年人出现致残性合并症的原因。减少老年人使用潜在不适当药物可能有助于预防这种情况。然而,研究表明患者不愿采取这种方法。本研究的目的是描述法国老年医学网络中接受治疗的老年患者在减少使用潜在不适当处方药物方面的障碍和态度。这项研究是一项非干预性、多中心、前瞻性横断面研究,对象是在法国老年医学网络住院的75岁及以上患者。使用经法语验证的“修订版患者对减药的态度”问卷收集数据。结果分析表明,患者对自己的治疗评价很高,并不认为治疗会带来困扰。尽管如此,虽然总体上60%的患者赞成这种方法,但他们似乎更不愿意停止服用抗高血压药、催眠药和苯二氮䓬类药物。这项研究有助于更好地理解法国老年人对减药的态度,并为鼓励关于治疗的讨论以及更好地接受减药开辟了实际途径。临床试验注册号:NCT05327634。
J Gerontol A Biol Sci Med Sci. 2021-5-22
J Am Med Dir Assoc. 2024-3
Front Public Health. 2022
J Gerontol A Biol Sci Med Sci. 2022-5-5
BMC Geriatr. 2021-6-16
Res Social Adm Pharm. 2020-10
J Am Geriatr Soc. 2019-12-2